ISI Journal Citation Reports @ Ranking: 2018: 42/136 (Medicine, Research & Experimental) Online ISSN: 1752-8062

Editor's Summary The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists. Find out more about the editorial board for Chronic Diseases and Translational Medicine. Science Immunology 05 Jun 2020 IL-22 signaling limits oral candidiasis via proliferation of basal epithelial cells and replenishment of an IL-17–responsive layer. Volume 06, Issue 03. A survey of in-vitro and in-vivo effects of steroids on melanoma growth and its implication on the nature of the disease. Editor's Summary Since 2005 he is Full Professor at the same institution. 2012 – 14), divided by the number of documents in these three previous years (e.g. Editor-in-Chief.

2012 – 14). Xiangdong Wang, MD, PhD, is a Distinguished Professor of Medicine at Fudan University, Director of Shanghai Institute of Clinical Bioinformatics, and Executive Director of Zhongshan Hospital Institute of Clinical Science, Fudan University. Editorial Board. Biography Current Issue Latest Articles Author Instructions. 2012 – 14), divided by the number of documents in these three previous years (e.g. The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. CiteScore: 4.48 ℹ CiteScore: 2019: 4.480 CiteScore measures the average citations received per document published in this title. 2015) to documents published in three previous calendar years (e.g. Science Immunology 05 Jun 2020 IL-22 signaling limits oral candidiasis via proliferation of basal epithelial cells and replenishment of an IL-17–responsive layer. Publons users have indicated that they sit on Science Translational Medicine's editorial board but we are unable to verify these claims. Translational Medicine Communications is an interdisciplinary forum for all scientifically valid research from across translational medicine. Translational Medicine; Primers; Gut Instincts; Advanced Search. Dr. Quest has more than 100 publications in international journals and is a member of the Editorial board of Cell Biology and Function (2013), Current Molecular Medicine (2014) and Biochemical Journal (2015).

The Annals of Translational Medicine’s specific areas of interest include, but not limited to multimodality therapy, biomarkers, imaging, biology, pathology, and technical advances related to medicine.

EDITOR-IN-CHIEF: Douglas L. Mann, MD, FACC. Impact factor: 3.989. Editorial board members on Publons.

Novel scientific discoveries and new therapies that improve clinical outcomes for cardiovascular disease patients .

Editorial Board Editor-in-Chief Xiangdong Wang, Fudan University, Shanghai, China. If you are an administrator for Science Translational Medicine, please get in touch to find out how you can verify the contributions of your editorial board members and more. Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science.. Editorial Board xxx yyy yyy yyy In Press Current Issue Archive Submit Manuscript Publication Charges External Databases & Indexes.

EDITOR IN CHIEF. Editorial Board (includes 3 members ... Department of Molecular Medicine University of Texas Health Science Center at San Antonio San Antonio, TX 78245-3207, USA : Yi-Ping Li, Ph.D. Jay McDonald Endowed Professor Department of Pathology The School of Medicine University of Alabama at Birmingham (UAB) Birmingham, Alabama 35294-2182, USA: Xinghua Lu, MD, PhD Professor, Dept. Ramaraj P. Editorial-Journal of Translational Science (JTS) May 27, 2019. The journal covers all areas of translational medicine but also has several specialized sections: Cancer microenvironment - Edited by Davide Bedognetti 2012 – 14). 2015) to documents published in three previous calendar years (e.g. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. CiteScore: 2.52 ℹ CiteScore: 2019: 2.520 CiteScore measures the average citations received per document published in this title. … CiteScore values are based on citation counts in a given year (e.g.

JACC: Basic to Translational Science. Journals › Editorial Board. Editorial Board. CiteScore values are based on citation counts in a given year (e.g. Home > Editorial Board.